For years, the cattle industry has relied on florfenicol (antibiotic) to treat bacterial causes of bovine respiratory disease (BRD). At the same time, the industry has relied on flunixin meglumine (NSAID) to treat the fever associated with BRD.
RESFLOR GOLD changes all that. It is a unique formulation of florfenicol and flunixin meglumine. We say RESFLOR GOLD is a “unique” formulation because florfenicol and flunixin meglumine cannot simply be mixed together to create RESFLOR GOLD. When they are mixed that way, a gelatinous substance results; it could not be administered by any route.
The technology that formulated RESFLOR GOLD brought with it two bonus features of the product:
What this new technology means to the cattle industry is that BRD therapy can now be provided simply, conveniently and cost-effectively.
For subcutaneous use in beef and non-lactating dairy cattle only. Not for use in female dairy cattle 20 months of age or older or in calves to be processed for veal. The effects of florfenicol and flunixin on bovine reproductive performance, pregnancy, and lactation have not been determined. When administered according to the label directions, RESFLOR GOLD may induce a transient local reaction in the subcutaneous and underlying muscle tissue. Click here for full product information.
